Stay updated on Risdiplam in SMA Infants Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Infants Clinical Trial page.
Latest updates to the Risdiplam in SMA Infants Clinical Trial page
- Check2 days agoChange DetectedStudy Locations updated to include Florida, New South Wales, São Paulo, and Moscow Oblast; related location entries were adjusted.SummaryDifference0.5%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedNew timestamp fields such as 'Last Update Posted (Estimated)' and related date updates appear on the page, while the core study details and criteria remain unchanged.SummaryDifference0.3%
- Check31 days agoChange DetectedThe PubMed publications note now states entries are automatically filled from PubMed and may not be about the study, and the revision label has been updated to v3.3.2.SummaryDifference0.1%
- Check38 days agoChange DetectedThe page-wide notice about government funding and NIH operating status has been removed. All study details and content remain unchanged.SummaryDifference0.3%
- Check53 days agoChange DetectedNo significant content changes detected on the Study Details page; the layout and information appear consistent between screenshots.SummaryDifference0.4%
- Check81 days agoChange DetectedSummary of changes: updated revision from v3.1.0 to v3.2.0, added a government operating-status notice and new resource entry for Spinal muscular atrophy.SummaryDifference3%
Stay in the know with updates to Risdiplam in SMA Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Infants Clinical Trial page.